Last updated on April 2019

The Combination Therapy With Ra-223 and Enzalutamide


Brief description of study

This study is to evaluate preliminary efficacy of Ra-223 in combination with Enzalutamide in progressive CRPC patients with bone metastasis

Clinical Study Identifier: NCT03305224

Find a site near you

Start Over